Stryker (SYK) Cash from Restructuring (2009 - 2010)
Stryker (SYK) reported Cash from Restructuring of $1.0 million for Q4 2010, down 96.96% year-over-year from $32.9 million in Q4 2009, and up 900.0% quarter-over-quarter from $100000.0 in Q3 2010.
Stryker (SYK) Cash from Restructuring (2009 - 2010) Analysis & Trends
Stryker (SYK) has 2 years of Cash from Restructuring data on file, last reported at $1.0 million in Q4 2010.
- Cash from Restructuring for Q4 2010 came in at $1.0 million, down 96.96% year-over-year; the trailing twelve-month figure through Dec 2010 was $38.7 million (up 1.57% YoY), and the FY2011 annual result was $29.0 million, up 222.22% from the prior year.
- Cash from Restructuring grew to $1.0 million in Q4 2010 per SYK's latest filing, from $100000.0 in the prior quarter.
- Over five years, Cash from Restructuring peaked at $32.9 million in Q4 2009 and troughed at $100000.0 in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 1.00 Mn |
| Sep 30, 2010 | 100,000.00 |
| Dec 31, 2009 | 32.90 Mn |
| Sep 30, 2009 | 4.70 Mn |